Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Kenneth A Pettine"'
Publikováno v:
Journal of Stem Cells Research, Development & Therapy. 5:1-5
Autor:
Kenneth A. Pettine, Maxwell Dordevic
Publikováno v:
Journal of Biomedical Research and Clinical Investigation. 1
Autor:
Maxwell Dordevic, Kenneth A. Pettine
Publikováno v:
Journal of Biomedical Research and Clinical Investigation. 1
Autor:
Donna D. Ohnmeiss, Jeffrey S. Roh, Paul C. McAfee, Kenneth A. Pettine, Thomas A. Dimmig, Domagoj Coric, Richard D. Guyer
Publikováno v:
SPINE. 41:3-8
STUDY DESIGN This was a prospective, randomized, controlled, multicenter study. OBJECTIVE The purpose of this study was to compare outcomes of two lumbar total disc replacements (TDRs) at 5-year follow-up and report results of serum ion level analysi
Publikováno v:
Journal of Stem Cell Research & Therapeutics. 4
The use of bone marrow concentrate BMC to treat Osteoarthritis OA is the standard of care in veterinary medicine There remains a paucity of clinical data on the safety and efficacy of utilizing BMC in humans Fifty one former N F L players were inject
Publikováno v:
International orthopaedics. 41(10)
The purpose of this study is to assess safety and feasibility of intradiscal bone marrow concentrate (BMC) injections to treat low back discogenic pain as an alternative to surgery with three year minimum follow-up. A total of 26 patients suffering f
Publikováno v:
Journal of Neurosurgery: Spine. 18:85-95
Object The purpose of the study was to evaluate the safety and initial efficacy of NuQu allogeneic juvenile chondrocytes delivered percutaneously for the treatment of lumbar spondylosis with mechanical low-back pain (LBP). NuQu is a cell-based biolog
Publikováno v:
International orthopaedics. 40(1)
The purpose of this study is to assess safety and feasibility of intradiscal bone marrow concentrate (BMC) injections to treat discogenic pain as an alternative to surgery. A total of 26 patients (11 male, 15 female, aged 18–61 years, 13 single lev
Publikováno v:
Stem cells (Dayton, Ohio). 33(1)
Degenerative disc disease (DDD) induces chronic back pain with limited nonsurgical options. In this open label pilot study, 26 patients (median age 40 years; range 18–61) received autologous bone marrow concentrate (BMC) disc injections (13 one lev
Autor:
Kenneth A. Pettine, Thomas A. Dimmig, Domagoj Coric, Jeffrey S. Roh, Donna D. Ohnmeiss, Paul C. McAfee, Richard D. Guyer
Publikováno v:
Spine. 39(12)
STUDY DESIGN This was a prospective, randomized, controlled multicenter study with 24-month follow-up. OBJECTIVE The purpose of this study was to evaluate the safety and efficacy in a Food and Drug Administration Investigation Device Exemption of a n